Trial NCT00210392

View at ClinicalTrials.gov 
Org. Study IDs: IELSG25B

Last trial update was posted on 2015-03-30

MeSH Interventions

Bortezomib

MeSH Conditions

Lymphoma Lymphoma, B-Cell, Marginal Zone

Other Conditions

Lymphoma, Mucosa-Associated Lymphoid Tissue

Stopping Reasons

After IELSG25A study amendment, patients subject of the present study were eligible for inclusion in the IELSG25A study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID